Skip to content

Shanghai Clinical Cohort - Obstructive Sleep Apnea-Hypopnea Syndrome

Shanghai Clinical Cohort - Obstructive Sleep Apnea-Hypopnea Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109966
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-09-29
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea hypopnea syndrome

Interventions

Observation Group of Obstructive Sleep apnea-hypopnea syndrome:None

Sponsors

Shanghai Sixth People's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in this clinical study and sign the informed consent; 2. Both sexes, baseline age >=18 years old; 3. Complete baseline demographic information, medical history information, anthropometric data, questionnaire information, PSG data, glucose and lipid biochemical indexes; (4) Baseline total sleep duration >=4 hours; 5. Willing to cooperate and have not participated in other clinical research projects in the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Previous diagnosis of sleep breathing disorders other than OSAHS, such as central sleep apnea syndrome, sleep-related alveolar hypoventilation disorder, etc. 2. Congenital cardiovascular, respiratory, metabolic, neurological, digestive, urinary and other system diseases, such as congenital ventricular septal defect, thoracic malformation, type 1 diabetes mellitus, glycogen storage disease, Down syndrome, congenital digestive or urinary tract malformation, etc. 3. Suffering from severe mental diseases such as mania and schizophrenia; 4. Suffering from tuberculosis, AIDS, syphilis and other infectious diseases; 5. Pregnant women; 6. Long-term use of steroid hormones or hormone replacement therapy; 7. Acute inflammatory phase; 8. Unable to cooperate with the completion of various examinations, tests, or provide biological samples. 9. Any reasons for not participating in the study considered by the investigator.

Design outcomes

Primary

MeasureTime frame
Polysomnography;CVD incidence;

Secondary

MeasureTime frame
Weight;Height;Neck circumference;Waist circumference;Hip circumference;Fasting blood glucose;Fasting blood lipids;Renal Liver Function;

Countries

China

Contacts

Public ContactYin Shankai

Shanghai Sixth People's hospital

skyin@sjtu.edu.cn+86 21 6483 4143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026